The Genetics of Cystic Fibrosis
The birth of a child with CF is often a total surprise to a family, since most of the time there is no previous family history of CF. Many autosomal recessive conditions occur this way. Since both parents are healthy, they had no prior knowledge that they carried the gene, nor that they passed the gene to the pregnancy at the same time.
Genes are founds on structures in the cells of our body called "chromosomes." There are normally 46 total, or 23 pairs of chromosomes in each cell of our body. The seventh pair of chromosomes contains a gene called the CFTR (cystic fibrosis transmembrane regulator) gene. Mutations or errors in this gene are what cause CF. This gene is quite large and complex. Over 1,000 different mutations in this gene have been found which cause CF.
The risk for having a mutation in the gene for CF depends on your ethnic background (for persons without a family history of CF):
|Ethnic Background||Risk of CF Mutation||Risk of Child with CF|
|Caucasian||1 in 29||1 in 3300|
|Ashkenazi Jewish||1 in 29||1 in 3300|
|Hispanic||1 in 46||1 in 8000-9000|
|African-American||1 in 65||1 in 15,300|
|Asian||1 in 90||1 in 32,100|
Testing for the CF gene can be done from a small blood sample or from a "cheek swab," which is a brush rubbed against the inside of your cheek to obtain cells for testing. Laboratories generally test for the most common mutations, and most labs test for anywhere from 30 to 100 total mutations. The detection rate depends on the person's ethnic background. In general, the detection rate for the Caucasian population is around 90 percent, 97 percent or more for the Ashkenazi population, 57 percent for Hispanics, 75 percent for African-Americans, and 30 percent for Asians. The detection rate differs because CF is more common in certain geographical areas and certain populations of the world. The diagnosis is confirmed by another test call the sweat chloride test.
There are many people with CF whose mutations have not been identified. In other words, all of the genetic errors that cause the disease have not been discovered. Because not all mutations are detectable, a person can still be a CF carrier even if no mutations were found by carrier testing.
Testing for the CF gene is recommended for anyone who has a family member with the disease, or whose partner is a known carrier of CF or affected with CF.
Lucile Packard Children's Hospital at Stanford is one of eight Cystic Fibrosis Foundation Therapeutic research centers.
Gene Therapy Research
This study examines the ability to safely replace a defective cystic fibrosis gene (CFTR) with one that is correctly coded (tgAAVCF) when it is administered as a single dose via nebulizer to the lungs of a CF patient. Additionally, the study looks at the delivery of the gene to the lung cells, and the cells' ability to make the correct protein after the single dose.
The more information or possible involvement in our clinical research program please call 650-723-5193.
Learn more about cystic fibrosis research at Lucile Packard Children's Hospital.
The information on this Web page is provided for educational purposes. You understand and agree that this information is not intended to be, and should not be used as, a substitute for medical treatment by a health care professional. You agree that Lucile Salter Packard Children's Hospital is not making a diagnosis of your condition or a recommendation about the course of treatment for your particular circumstances through the use of this Web page. You agree to be solely responsible for your use of this Web page and the information contained on this page. Lucile Salter Packard Children's Hospital, its officers, directors, employees, agents, and information providers shall not be liable for any damages you may suffer or cause through your use of this page even if advised of the possibility of such damages.